A Study to Evaluate the Safety and Effectiveness of a Contact Lens Cleaning and Disinfecting Solution

Inclusion criteria

• Is of legal age (at least 18) on the date the Informed Consent Form (ICF) is signed
• Is able to read, understand, and provide written informed consent on the Institutional Review Board (IRB)/Ethics Committee (EC) approved ICF and provide authorization as appropriate for local privacy regulations
• Is a habitual wearer (at least 3 months)
• Has typically cleaned and disinfected their pre-study contact lenses daily
• Must have spectacle correctable distance visual acuity through spherocylindrical refraction to 40 letters (0.14 logarithm of the minimal angle of resolution (logMAR) or better in each eye, at 2 meters distance with high contrast chart
• Has clear central corneas and is free of any anterior segment disorders
• Is a habitual user of a lens care product for cleaning, disinfecting, and storage of lenses
• Requires lens correction in both eyes
• Wears the same manufacturer and brand of lens in both eyes
• Agrees to wear study lenses on a daily wear basis for approximately three months
• Is willing and able to comply with all treatment and follow-up/study procedures.

Exclusion criteria

• Is currently using a hydrogen-peroxide cleaning and disinfecting solution
• Participated in any drug or device clinical investigation within 30 days prior to entry into this study
• Is a female of childbearing potential (those who are not surgically sterilized or postmenopausal) if they meet any one of the following conditions:

• they are currently pregnant
• they plan to become pregnant during the study
• they are breastfeeding
• Has worn gas permeable (GP) lenses within the last 30 days
• Has worn polymethylmethacrylate (PMMA) lenses within the last three months
• Has typically worn their pre-study contact lenses on an extended wear basis, sleeping in their lenses one night or more per week, during the last year
• Has any systemic disease currently affecting ocular health or which in the Investigator's opinion may have an effect on ocular health during the course of the study
• Subjects with an active ocular disease, or who are using any ocular medication.
• Is using any medications that will, in the Investigator's opinion, affect ocular physiology or lens performance
• Currently wears monovision, multifocal, or toric contact lenses
• Has ocular astigmatism of 1.00D or greater in either eye
• Has anisometropia (spherical equivalent) of greater than 2.00D
• Has any grade 2 or greater finding during the slit-lamp examination (refer to Appendix B for Methods of Clinical Evaluation)
• Has corneal infiltrates, of ANY GRADE
• Has any "Present" ungraded finding during the slit-lamp examination (refer to Appendix B for Methods of Clinical Evaluation) that, in the Investigator's judgment, interferes with contact lens wear.
• Has typically worn their pr-study control lenses on an extended wear bases, sleeping on their lenses one night or more per week, during the last year.
• Is aphakic
• Is amblyopic
• Has had any corneal surgery (e.g., refractive surgery)
• Is allergic to any component in the study care products.
• Is an employee of any of the study investigative sites or a family member of an employee of the investigative site, including family members living outside of the employee's household
• Is an Ophthalmologist, an Optometrist, an Optician, or an Ophthalmic Assistant/Technician, or currently resides with a person with any of these specialties
• Is an employee of a manufacturer of contact lenses or contact lens care products (e.g., Alcon, Bausch + Lomb, Ciba Vision, CooperVision, Vistakon, Johnson & Johnson, etc.) or currently resides with a person employed by any of these manufacturers.